[#item_full_content] Now that Vertanical’s Exilby has been approved in Germany to treat chronic pain, Clemens Fischer, the pharma billionaire behind it, has set his sights on the U.S. market. 
Read More
[#item_full_content] Now that Vertanical’s Exilby has been approved in Germany to treat chronic pain, Clemens Fischer, the pharma billionaire behind it, has set his sights on the U.S. market. Read More